| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |